Erica Moretti
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 10%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
Papers in
- Oncology 15
- HER2/EGFR in Cancer Research 11
- Cancer Treatment and Pharmacology 6
- Cancer-related Molecular Pathways 3
-
- Breast Cancer Treatment Studies 7
- Cancer Genomics and Diagnostics 6
- Co-authors
- Angelo Di Leo (21 shared papers)Libero Santarpia (7 shared papers)Laura Biganzoli (21 shared papers)Ilenia Migliaccio (14 shared papers)Luca Malorni (18 shared papers)Aman U. Buzdar (1 shared paper)George A. Călin (1 shared paper)Robert C. Bast (1 shared paper)
- Journals
- Cancer Treatment Reviews (3 papers)Future Oncology (2 papers)American Society of Clinical Oncology Educational Book (2 papers)The Breast (2 papers)Breast Cancer Research (2 papers)
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Erica Moretti
29 papers receiving 646 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 324
- Oncology 220
- Molecular Biology 326
- Pulmonary and Respiratory Medicine 140
- Genetics 24
Countries citing papers authored by Erica Moretti
This map shows the geographic impact of Erica Moretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica Moretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica Moretti more than expected).
Fields of papers citing papers by Erica Moretti
This network shows the impact of papers produced by Erica Moretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica Moretti. The network helps show where Erica Moretti may publish in the future.
Co-authors
The 25 scholars most cited alongside Erica Moretti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 223 | |
| 2 | 2013 | 107 | |
| 3 | 2020 | 49 | |
| 4 | 2020 | 39 | |
| 5 | 2021 | 28 | |
| 6 | 2021 | 26 | |
| 7 | 2009 | 25 | |
| 8 | 2019 | 20 | |
| 9 | 2018 | 15 | |
| 10 | 2019 | 15 | |
| 11 | 2011 | 14 | |
| 12 | 2017 | 13 | |
| 13 | 2008 | 13 | |
| 14 | 2013 | 11 | |
| 15 | 2009 | 9 | |
| 16 | 2011 | 9 | |
| 17 | 2018 | 7 | |
| 18 | 2018 | 7 | |
| 19 | 2024 | 4 | |
| 20 | 2011 | 4 |
About Erica Moretti
Erica Moretti is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Genetics, having authored 31 papers that have together received 656 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (11 papers), Advanced Breast Cancer Therapies (9 papers), Breast Cancer Treatment Studies (7 papers), Cancer Genomics and Diagnostics (6 papers), Cancer Treatment and Pharmacology (6 papers), Epigenetics and DNA Methylation (3 papers), Single-cell and spatial transcriptomics (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Cancer Research (324 citations), Oncology (220 citations), Molecular Biology (326 citations), Pulmonary and Respiratory Medicine (140 citations) and Genetics (24 citations). Erica Moretti has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Angelo Di Leo, Libero Santarpia, Laura Biganzoli, Ilenia Migliaccio, Luca Malorni, Aman U. Buzdar, George A. Călin, Robert C. Bast, Ju‐Yeon Kim and Xiao‐Feng Le. Their work appears in journals such as Cancer Treatment Reviews, Future Oncology, American Society of Clinical Oncology Educational Book, The Breast and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.